164 related articles for article (PubMed ID: 38416679)
1. NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells.
Saito Y; Yang Y; Saito M; Park CY; Funato K; Tabar V; Darnell RB
Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2314695121. PubMed ID: 38416679
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
[TBL] [Abstract][Full Text] [Related]
3. NOVA1 acts on Impact to regulate hypothalamic function and translation in inhibitory neurons.
Tajima Y; Ito K; Yuan Y; Frank MO; Saito Y; Darnell RB
Cell Rep; 2023 Feb; 42(2):112050. PubMed ID: 36716149
[TBL] [Abstract][Full Text] [Related]
4. MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma.
Zhi F; Wang Q; Deng D; Shao N; Wang R; Xue L; Wang S; Xia X; Yang Y
PLoS One; 2014; 9(10):e109124. PubMed ID: 25299073
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of FGF9 and NOVA1 in cancer-associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.
Zhang B; Liu Y; Yu J; Lin X
Drug Dev Res; 2024 May; 85(3):e22185. PubMed ID: 38657094
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3).
Yang CH; Yue J; Pfeffer SR; Fan M; Paulus E; Hosni-Ahmed A; Sims M; Qayyum S; Davidoff AM; Handorf CR; Pfeffer LM
J Biol Chem; 2014 Sep; 289(36):25079-87. PubMed ID: 25059666
[TBL] [Abstract][Full Text] [Related]
7. RNA-binding protein NOVA1 promotes acute T-lymphocyte leukemia progression by stabilizing USP44 mRNA.
Zhang B; Sun R; Gu M; Jiang Z; Wang Y; Zhang L; Liu X; Chi Z
Biochem Cell Biol; 2024 Feb; 102(1):60-72. PubMed ID: 37816258
[TBL] [Abstract][Full Text] [Related]
8. MiRNA-138-5p protects the early diabetic retinopathy by regulating NOVA1.
Bao XY; Cao J
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7749-7756. PubMed ID: 31599400
[TBL] [Abstract][Full Text] [Related]
9. NOVA1 acts as an oncogene in melanoma via regulating FOXO3a expression.
Yu X; Zheng H; Chan MTV; Wu WKK
J Cell Mol Med; 2018 May; 22(5):2622-2630. PubMed ID: 29498217
[TBL] [Abstract][Full Text] [Related]
10. MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1.
Liu XM; Li XF; Li JC
Kaohsiung J Med Sci; 2021 Apr; 37(4):286-293. PubMed ID: 33340248
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
12. NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal.
Yoon SO; Kim EK; Lee M; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI
Oncotarget; 2016 Jan; 7(3):2475-95. PubMed ID: 26673617
[TBL] [Abstract][Full Text] [Related]
13. A large-scale functional screen identifies Nova1 and Ncoa3 as regulators of neuronal miRNA function.
Störchel PH; Thümmler J; Siegel G; Aksoy-Aksel A; Zampa F; Sumer S; Schratt G
EMBO J; 2015 Sep; 34(17):2237-54. PubMed ID: 26105073
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1.
Kouhkan F; Mobarra N; Soufi-Zomorrod M; Keramati F; Hosseini Rad SM; Fathi-Roudsari M; Tavakoli R; Hajarizadeh A; Ziaei S; Lahmi R; Hanif H; Soleimani M
J Med Genet; 2016 Jan; 53(1):24-33. PubMed ID: 26510428
[TBL] [Abstract][Full Text] [Related]
15. NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells.
Sayed ME; Yuan L; Robin JD; Tedone E; Batten K; Dahlson N; Wright WE; Shay JW; Ludlow AT
Oncogene; 2019 Apr; 38(16):2937-2952. PubMed ID: 30568224
[TBL] [Abstract][Full Text] [Related]
16. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling.
Qu L; Tian Y; Wang F; Li Z
BMC Cancer; 2022 Oct; 22(1):1091. PubMed ID: 36284263
[TBL] [Abstract][Full Text] [Related]
17. High expression of neuro-oncological ventral antigen 1 correlates with poor prognosis in hepatocellular carcinoma.
Zhang YA; Zhu JM; Yin J; Tang WQ; Guo YM; Shen XZ; Liu TT
PLoS One; 2014; 9(3):e90955. PubMed ID: 24608171
[TBL] [Abstract][Full Text] [Related]
18. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.
Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO
Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018
[TBL] [Abstract][Full Text] [Related]
19. Post-transcriptional regulation of neuro-oncological ventral antigen 1 by the neuronal RNA-binding proteins ELAV.
Ratti A; Fallini C; Colombrita C; Pascale A; Laforenza U; Quattrone A; Silani V
J Biol Chem; 2008 Mar; 283(12):7531-41. PubMed ID: 18218628
[TBL] [Abstract][Full Text] [Related]
20. The RNA binding protein neuro-oncological ventral antigen 1 (NOVA1) regulates IL-6 mRNA stability to enhance JAK2-STAT3 signaling in CRC.
Hong YG; Xu GS; Yu GY; Zhou JD; Liu QZ; Ni JS; Yan HL; Zhang W; Hao LQ
Surg Oncol; 2019 Dec; 31():67-74. PubMed ID: 31541909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]